Signatur Biosciences Analysis: $500K Raised
What is Signatur Biosciences?
Signatur Biosciences develops PCR kits for diagnosing complex diseases by detecting gene expression signatures with standard lab equipment.
Founded
2022
Company Stage
Pre-Seed
YC Batch
S22
Product Features & Capabilities
- Smart PCR kits for detecting complex diseases, integration with standard qPCR machines, ability to analyze multiple RNA biomarkers, simplified workflows for precision diagnostics, technology designed for existing clinical infrastructure.
How much Signatur Biosciences raised
s: - $500,000
August 22, 2022Lead Investor: Y Combinator
Who are the founders of Signatur Biosciences
JG
John Goertz
Co-founder, CSO
CD
Celestin de Wergifosse
Co-founder, CEO
Investors
- Myelin VC
- PSR Crypto
- Riceberg Ventures
- Imperial College London
